Aspen is an API and finished-dose manufacturer based in United Arab Emirates. It appears in 547 regulatory filings across 18 regulators, without an active US DMF or CEP on file. Its filings concentrate with INHRR (VE), INVIMA (CO) and MHRA (UK). Its GMP standing is certified by COFEPRIS (MX) and NAFDAC (NG).
| Site | FDA FEI |
|---|---|
| Port Elizabeth, United Arab Emirates | Not on file |
| Azcapotzalco, Mexico | Not on file |
| Cnr. Fairclough Road & gibaud Road Korsten port Elizabeth South Africa, Nigeria | Not on file |
| Molecule | Regulators | Docs |
|---|---|---|
| Progesterone | SFDA (Saudi Arabia) | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| INHRR (VE) | 267 | None |
| INVIMA (CO) | 60 | None |
| MHRA (UK) | 59 | None |
| DKMA (DK) | 37 | None |
| US FDA | 33 | None |
| ANMAT (AR) | 20 | None |
| COFEPRIS (MX) | None | 2 |
| NAFDAC (NG) | None | 2 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2023 | $60.0B | Not reported | Not reported |
| 2022 | $40.0B | Not reported | Not reported |
| 2021 | $60.0B | Not reported | Not reported |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. Aspen comes back tiered against every other supplier able to file there.
Start for free